Retatrutide: A triple-agonist (GLP-1/GIP/glucagon) that targets multiple metabolic pathways and has shown impressive weight loss results in studies
Shang, L., Dong, S
K., Wolfe, K., Patel, B., Thewissen, R., Zaborina, O., & Alverdy, J
SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
Rare Risk of Delayed Gastric Emptying: Although uncommon, some individuals may experience slowed digestion, affecting nutrient absorption and overall comfort
The UK's approach differs slightly from recommendations by the European Food Safety Authority (EFSA) , which sets an Adequate Intake of 4 mcg per day for adults, reflecting a more cautious margin of safety